Clinical Trial Update: Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial of istradefylline (KW-6002) for restless legs syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• istradefylline (istradefylline)

Snippet

Sponsor: Kyowa Kirin, Inc. | Conditions: Sleep Disorder, Restless Legs Syndrome | Phase 2 | Status: COMPLETED